作者：
Lachmann,N. [1]
;
Happle,C. [2]
;
Ackermann,M. [3]
;
Lüttge,D. [4]
;
Wetzke,M. [5]
;
Merkert,S. [6]
;
Hetzel,M. [7]
;
Kensah,G. ;
Jara-Avaca,M. ;
Mucci,A. ;
Skuljec,J. ;
Dittrich,A.-M. ;
Pfaff,N. ;
Brennig,S. ;
Schambach,A. ;
Steinemann,D. ;
G?hring,G. ;
Cantz,T. ;
Martin,U. ;
Schwerk,N. ;
Hansen,G. ;
Moritz,T.
作者单位：
Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School
[1]
Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
[2]
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), German Center for Lung
[3]
Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Carl
[4]
Reprogramming and Gene Therapy Group, REBIRTH Cluster of Excellence, Hannover Medical School, Carl
[5]
Institute of Experimental Hematology, Hannover, Germany, REBIRTH Research Group Stem Cell Biology
[6]
Leibniz Research Laboratories for Biotechnology and Artificial Organs, Department of Cardiothoracic
[7]
发布时间
2014-04-03
换一批
换一批
